International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3, Supplement , Pages S3-S9 , 1 March 2010

Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues

  • Søren M. Bentzen, Ph.D., D.Sc.

      Affiliations

    • Departments of Human Oncology, Medical Physics, Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, WI
    • Corresponding Author InformationReprint requests to: Søren M. Bentzen, Ph.D., D.Sc., University of Wisconsin School of Medicine and Public Health, Department of Human Oncology, K4/316 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792. Tel: (608) 265-8572; Fax: (608) 263-9947
    • ,
  • Louis S. Constine, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY
    • ,
  • Joseph O. Deasy, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Washington University, St. Louis, MO
    • ,
  • Avi Eisbruch, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • ,
  • Andrew Jackson, Ph.D.

      Affiliations

    • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY
    • ,
  • Lawrence B. Marks, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, NC
    • ,
  • Randall K. Ten Haken, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Michigan, Ann Arbor, MI
    • ,
  • Ellen D. Yorke, Ph.D.

      Affiliations

    • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY

Received 8 April 2009 ,Revised 1 September 2009 ,Accepted 2 September 2009.

References 

  1. Bentzen SM, Rosenthal DI, Weymuller E. Increasing toxicity in non-operative head and neck cancer treatment: Investigations and interventions. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S79–S82
  2. Center for Disease Control (USA). Cancer survivorship—United States, 1971–2001. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5324a3.htm. Accessed December 1, 2005.
  3. Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol. 2007;25:4096–4103
  4. Trotti A, Bentzen SM. The need for adverse effects reporting standards in oncology clinical trials. J Clin Oncol. 2004;22:19–22
  5. Papanikolaou PN, Ioannidis JP. Availability of large-scale evidence on specific harms from systematic reviews of randomized trials. Am J Med. 2004;117:582–589
  6. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0. Available at http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf. Accessed February 9, 2009.
  7. Bentzen SM, Dorr W, Anscher MS, et al. Normal tissue effects: Reporting and analysis. Semin Radiat Oncol. 2003;13:189–202
  8. Peeters ST, Lebesque JV, Heemsbergen WD, et al. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64:1151–1161
  9. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  10. Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123–135
  11. Lyman JT. Complication probability as assessed from dose-volume histograms. Rad Res. 1985;104:S-13–S-19
  12. Kutcher GJ, Burman C, Brewster L, et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 1991;21:137–146
  13. Schultheiss TE, Orton CG, Peck RA. Models in radiotherapy: Volume effects. Med Phys. 1983;10:410–415
  14. Withers HR, Taylor JM, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 1988;14:751–759
  15. Källman P, Aagren A, Brahme A. Tumour and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol. 1992;62:249–262
  16. Liao ZX, Travis EL, Tucker SL. Damage and morbidity from pneumonitis after irradiation of partial volumes of mouse lung [see comments]. Int J Radiat Oncol Biol Phys. 1995;32:1359–1370
  17. Tucker SL, Liao ZX, Travis EL. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys. 1997;38:1055–1066
  18. Konings AW, Faber H, Cotteleer F, et al. Secondary radiation damage as the main cause for unexpected volume effects: A histopathologic study of the parotid gland. Int J Radiat Oncol Biol Phys. 2006;64:98–105
  19. van Luijk P, Faber H, Meertens H, et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys. 2007;69:552–559
  20. Hopewell JW, Trott KR. Volume effects in radiobiology as applied to radiotherapy. Radiother Oncol. 2000;56:283–288
  21. Trott KR, Tamou S, Sassy T, et al. The effect of irradiated volume on the chronic radiation damage of the rat large bowel. Strahlenther Onkol. 1995;171:326–331
  22. Peeters ST, Hoogeman MS, Heemsbergen WD, et al. Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: Normal tissue complication probability modeling. Int J Radiat Oncol Biol Phys. 2006;66:11–19
  23. Stewart FA, van der Kogel AJ. Volume effects in normal tissues. In:  Steel GG editors. Basic clinical radiobiology. 3rd ed. London: Arnold; 2002;p. 42–51
  24. van Luijk P, Bijl HP, Konings AW, et al. Data on dose-volume effects in the rat spinal cord do not support existing NTCP models. Int J Radiat Oncol Biol Phys. 2005;61:892–900
  25. Fiorino C, Fellin G, Rancati T, et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: Preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys. 2008;70:1130–1137
  26. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer. 2006;6:702–813
  27. Dawson LA, Biersack M, Lockwood G, et al. Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys. 2005;62:829–837
  28. Stavreva N, Niemierko A, Stavrev P, et al. Modelling the dose-volume response of the spinal cord, based on the idea of damage to contiguous functional subunits. Int J Radiat Biol. 2001;77:695–702
  29. El Naqa I, Bradley J, Blanco AI, et al. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys. 2006;64:1275–1286
  30. Gulliford SL, Webb S, Rowbottom CG, et al. Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. Radiother Oncol. 2004;71:3–12
  31. Chen S, Zhou S, Yin FF, et al. Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis. Med Phys. 2007;34:3808–3814
  32. Khuntia D, Harris J, Bentzen SM, et al. Increased oral mucositis after IMRT versus non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: Preliminary results of RTOG 0234 [abstract]. Int J Radiat Oncol Biol Phys. 2008;72:S33
  33. Tucker SL, Liu HH, Wang S, et al. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;66:754–761
  34. Tucker SL, Dong L, Cheung R, et al. Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60:1589–1601
  35. De Ruysscher D, Dehing C, Bremer RH, et al. Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients. Ann Oncol. 2007;18:909–916
  36. Bradley JD, Hope A, El N, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 93-11 and institutional data. Int J Radiat Oncol Biol Phys. 2007;69:985–992
  37. Tsougos I, Nilsson P, Theodorou K, et al. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol. 2007;52:1055–1073
  38. Yorke ED, Kutcher GJ, Jackson A, et al. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol. 1993;26:226–237
  39. Deasy JO, Niemierko A, Herbert D, et al. Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys. 2002;29:2109–2127
  40. Lawrence TS, Kessler ML, Robertson JM. 3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience. Front Radiat Ther Oncol. 1996;29:221–228
  41. Adkison JB, Khuntia D, Bentzen SM, et al. Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: Preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat. 2008;7:441–448
  42. Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65:1075–1086
  43. van Baardwijk A, Bosmans G, Boersma L, et al. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: A feasibility study. Int J Radiat Oncol Biol Phys. 2008;71:1394–1401

PII: S0360-3016(09)03300-8

doi: 10.1016/j.ijrobp.2009.09.040

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3, Supplement , Pages S3-S9 , 1 March 2010

Article Tools